DuPont extends Danisco offer deadline for a second time
DuPont has extended its $6.3bn takeover bid for Danish biotech firm Danisco for the second time, after holders of only six percent of Danisco’s shares have accepted the offer.
News, Analysis & Insights on Nutrition, Supplements, and Health
DuPont has extended its $6.3bn takeover bid for Danish biotech firm Danisco for the second time, after holders of only six percent of Danisco’s shares have accepted the offer.
There is no evidence to indicate that multivitamin use is associated with risk of cancer, cardiovascular disease, and overall risk of death, according to new research.
Special edition: Nutrigenomics
The benefits of nutrigenomics tools to illuminate the effect of certain nutrients on genes are occurring right now, but talk of personalized nutrition should be left for the future, says a DSM corporate scientist.